Media mention: ‘Membrane Technology Significantly Intensifies Gene Therapy Manufacturing’

May 19, 2025

Where: Chemical Engineering Progress, “Catalyzing Commercialization: Membrane Technology Significantly Intensifies Gene Therapy Manufacturing 

Who: Penn State researchers in collaboration with the University of Arkansas and Spark Therapeutics, through the U.S. National Science Foundation-funded Membrane Applications Science and Technology (MAST) Center 

What: A recent article in Chemical Engineering Progress, the flagship magazine of the American Institute of Chemical Engineers, highlights collaborative research led by the MAST Center, including Penn State researchers, on a novel single-pass tangential flow filtration system that intensifies the production of adeno-associated viral vectors used in gene therapy. The innovative process eliminates the need for recirculation, reduces shear stress on the product and significantly improves purification efficiency — marking a key advancement toward continuous and cost-effective adeno-associated viruses manufacturing. 

 

Share this story:

facebook linked in twitter email

MEDIA CONTACT:

College of Engineering Media Relations

communications@engr.psu.edu

“This project… [marked] a significant step towards the development of intensified and/or continuous platform processes for gene therapy manufacturing.” — Christopher Yehl, senior scientist at Spark Therapeutics and advisory board member with the MAST Center